Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Subjects
Condition: HER2-positive Recurrent / Metastatic Breast Cancer Interventions: Drug: pyrotinib tablet; Drug: Montmorillonite Power; Drug: Loperamide Sponsor: Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials